These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3282531)

  • 1. Pimobendane (UD-CG 115 BS) in the treatment of severe congestive heart failure. An acute haemodynamic cross-over and double-blind study with two different doses.
    Walter M; Liebens I; Goethals H; Renard M; Dresse A; Bernard R
    Br J Clin Pharmacol; 1988 Mar; 25(3):323-9. PubMed ID: 3282531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure.
    Baumann G; Ningel K; Permanetter B
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S23-30. PubMed ID: 2478788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pimobendane (UD-CG 115 BS) in chronic congestive heart failure. Short-term and one-month effects of a new inotropic vasodilating agent.
    Renard M; Walter M; Liebens I; Dresse A; Bernard R
    Chest; 1988 Jun; 93(6):1159-64. PubMed ID: 3371093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of intravenous UD-CG 115 BS (pimobendan) on the cardiovascular system and left ventricular pump function.
    Permanetter B; Sebening H; Hartmann F; Klein G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S36-40. PubMed ID: 2478790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Baumann G; Ningel K; Permanetter B
    J Cardiovasc Pharmacol; 1989 May; 13(5):730-8. PubMed ID: 2472521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects and plasma level profile of pimobendan (UD-CG 115 BS) and its metabolite UD-CG 212 in patients with congestive heart failure after single and repeated oral dosing.
    Hagemeijer F; Brand HJ; Roth W
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):302-10. PubMed ID: 2476606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute and chronic effects of UDCG 115 BS (pimobendan) in patients with advanced myocardial failure].
    Permanetter B; Baumann G; Wirtzfeld A; Günes S; Stinshoff M; Klein G
    Z Kardiol; 1989 May; 78(5):335-42. PubMed ID: 2660451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and long-term hemodynamic effects of pimobendan (UD-CG 115 BS) in comparison with captopril.
    Hauf GF; Grom E; Jähnchen E; Roskamm H
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S49-56. PubMed ID: 2478793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between the cardiovascular effects of pimobendan and plasma concentrations of the parent compound and of its major active metabolite, UD-CG 212 CL, in patients with congestive heart failure.
    Hagemeijer F; Roth W; Brand HJ
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S57-64. PubMed ID: 2478794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic haemodynamic actions of pimobendan (UD-CG 115 BS) and its O-demethylmetabolite UD-CG 212 Cl in the conscious pig.
    Duncker DJ; Hartog JM; Levinsky L; Verdouw PD
    Br J Pharmacol; 1987 Jul; 91(3):609-15. PubMed ID: 3607369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute and long-term effects of pimobendan (UD-CG 115) in NYHA II and III heart failure. Results of a randomized multicenter double-blind study].
    Assmann I; Kassel P; Duck HG; Fiehring H; Morgan P; Schmidt PK; Höfs T; Nehmiz G
    Z Kardiol; 1991 Nov; 80(11):687-94. PubMed ID: 1792811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure.
    Lilleberg J; Laine M; Palkama T; Kivikko M; Pohjanjousi P; Kupari M
    Eur J Heart Fail; 2007 Jan; 9(1):75-82. PubMed ID: 16829185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of a new type III phosphodiesterase inhibitor (CI-914) for congestive heart failure.
    Jafri SM; Burlew BS; Goldberg AD; Rogers A; Goldstein S
    Am J Cardiol; 1986 Feb; 57(4):254-9. PubMed ID: 3511661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive haemodynamic effects of piroximone and prostacyclin in severe chronic heart failure.
    Albo C; Saal JP; Lellouche D; Habbal R; Benvenuti C; Deleuze P; Loisance D; Castaigne A; Dubois-Randé JL
    Eur Heart J; 1994 Apr; 15(4):528-33. PubMed ID: 8070481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium sensitization with pimobendan: pharmacology, haemodynamic improvement, and sudden death in patients with chronic congestive heart failure.
    Hagemeijer F
    Eur Heart J; 1993 Apr; 14(4):551-66. PubMed ID: 8472722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure.
    Ponikowski P; Mitrovic V; Ruda M; Fernandez A; Voors AA; Vishnevsky A; Cotter G; Milo O; Laessing U; Zhang Y; Dahlke M; Zymlinski R; Metra M
    Eur Heart J; 2014 Feb; 35(7):431-41. PubMed ID: 24255129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma concentration-effect relationship of felodipine intravenously in patients with congestive heart failure.
    Dunselman PH; Edgar B; Scaf AH; Kuntze CE; van Bruggen A; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):438-43. PubMed ID: 2476624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravenous pimobendan (UDCG 115 BS) on hemodynamics and left ventricular volumes in idiopathic dilative cardiomyopathy.
    Permanetter B; Sebening H; Hartmann F; Baumann G; Lutilsky L
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):803-9. PubMed ID: 2481765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of captopril in heart failure complicating acute myocardial infarction and persistence of acute haemodynamic effects in chronic heart failure after 3 years of treatment.
    Mattioli G; Ricci S; Rigo R; Fusaro MT; Cappello C
    Postgrad Med J; 1986; 62 Suppl 1():164-6. PubMed ID: 3534855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of UD-CG 212 CL, a metabolite of pimobendan, in anaesthetized pigs.
    Verdouw PD; Levinsky L; Duncker DJ; Rutteman AM; Saxena PR
    Eur J Pharmacol; 1987 Jun; 137(2-3):219-26. PubMed ID: 2886352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.